This protocol applies to patients with a confirmed endometrial polyp who are entirely asymptomatic — no abnormal uterine bleeding — and whose polyp measures less than 10 mm. In this specific setting, the natural history and the associated malignancy risk differ meaningfully from symptomatic or larger polyps, and management is tailored accordingly.
Conservative management is recognised as a reasonable approach, particularly for small polyps in the absence of symptoms (Level A evidence). Evidence indicates that a meaningful proportion of small polyps may regress spontaneously, with smaller polyps more likely to resolve on their own compared with those 10 mm or greater. For asymptomatic postmenopausal patients, observation following a discussion of risks and preferences is also considered a valid option.
Conservative management is reasonable, particularly for small polyps and if asymptomatic (Level A).
There is Class II evidence that polyps may spontaneously regress in approximately 25% of cases, with smaller polyps more likely to regress compared with polyps >10 mm in length.
Asymptomatic postmenopausal polyps are unlikely to be malignant and observation is an option after discussion with the patient.
Hysteroscopic polypectomy is effective and safe as both a diagnostic and therapeutic intervention.
Hysteroscopic polypectomy remains the gold standard for treatment (Level B).
View source ↗